Abstract:Objective:To investigate the effectiveness of surgical treatment for patients with T 4 stage prostate cancer. Methods:The clinical data and prognosis of 18 patients with T 4 stage prostate cancer treated in Shanghai Tenth People's Hospital from July 2013 to December 2019 were retrospectively analyzed. The average age of these 18 patients was 68.3 (53-81)years. 10 patients were castration resistant prostate cancer (CRPC) and 8 patients were hormone-sensitive prostate cancer (HSPC). 10 CRPC patients were treated with surgical treatment due to bladder clot packing and/or lower urinary tract obstruction. 8 HSPC patients had severe hematuria, severe dysuria and local symptoms. The KPS scores of all patients were ≥80 points with an average score of 84 (80-90). The average QOL score of 18 patients was 28 (21-32). 2 cases in 18 patients underwent total pelvic resection for rectal invasion (one CRPC and one HSPC). 7 cases underwent radical cystoprostatectomy for ureteral invasion (5 cases of CRPC, 2 cases of HSPC), 9 cases underwent bladder preservation surgery for bladder neck invasion (4 cases of CRPC, 5 cases of HSPC), of which 4 cases of enlarged lymph node dissection were all HSPC patients. Results:All cases of T 4 stage prostate cancer patients operation were successfully completed, the average operation time was 256 (219-310)min and the median intraoperative blood loss was about 300 (250-350)ml. Four of them (3 cases of CRPC and 1 case of HSPC) received blood transfusion after operation. The average postoperative hospital stay was 21(11-37) days. All 18 cases were followed up and the median follow-up time was 23.8 months. There was no perioperative death, and no bladder-preserving patients had true urinary incontinence or bladder outlet stenosis.2 CRPC cases died 8 and 15 months after surgery respectively, 7 patients were PSA relapse treated with docetaxel or abiterone therapy, and 1 HSPC patient with rectal invasion was followed up for 58 months after total pelvic resection, the PSA level was still 0.003ng/ml, no distant metastasis was found. 8 cases of hormone-sensitive patients were treated with endocrine therapy, and PSA was less than 0.2 ng/ml. The average QOL of 18 patients 3 months after operation was 37 points (25-45), which was significantly higher than that before operation. The average maximum urine flow rate of patients with bladder preservation was 23(19-25)ml/s. Conclusions:For T 4 stage prostate cancer, surgical treatment is feasible and safe for doctors with extensive surgical experience. For CRPC patients, the surgery can significantly improve short-term symptoms and quality of life, and long-term benefits need to be further evaluated with a large sample. For HSPC patients, it can not only improve clinical symptoms and QOL of patients, but also provide long-term benefits.

Radical prostatectomy for incidental prostate cancer in TURP

Management of Biochemical Recurrence after Radical Prostatectomy for Prostate Cancer

High-risk benign prostatic hyperplasia patients treated with transurethral resection of prostate

Radical Retropubic Prostatectomy (with a Report of 53 Cases)

Retrospective analysis of incidental prostatic carcinoma after surgery of BPH:ten years' results

Retroperitoneal laparoscopic radical nephrectomy and regional clearance of lymph nodes(report of 40 cases)

Experience of laparoscopic radical prostatectomy for high risk protate cancer

Laparoscopic radical prostatectomy for incidental prostate cancer after TURP

Successful treatment of incidental prostate cancer by radical transurethral resection of prostate cancer

Report of 19 Cases of Transurethral Prostatic Resection while Improve Tension-free hernioplasty

Transurethral vapor-resection of the prostate for bladder outlet obstruction in patients with advanced prostate cancer

Retroperitoneal laparoscopic partial nephrectomy (report of 23 cases)

A Study of Diagnosis and Treatment of Prostate Cancer (Report of 41 Cases)

Incidental Prostate Cancer after Transurethral Resection of Prostatea——a Retrospective Analysis of 24 Cases

Radical cystectomy with distal prostate capsule sparing for bladder cancer

Transurethral Resection of the the Prostate for Lower Urinary Tract Obstruction from Advanced Prostate Cancer

Extraperitoneal laparoscopic radical prostatectomy for prostate cancer

Transurethral electrovaporization of benign prostatic hyperplasia

Therapeutic effect analysis of radical prostatectomy for 215 cases of prostate cancer

Impact of Plasmakinetic Resection of Prostate on Sexual Function in Patients with Benign Prostatic Hyperplasia

The experience of surgical treatment in T 4 stage prostate cancer